The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings

被引:58
作者
Jenner, LJ
Seman, LJ
Millar, JS
Lamon-Fava, S
Welty, FK
Dolnikowski, GG
Marcovina, SM
Lichtenstein, AH
Barrett, PHR
deLuca, C
Schaefer, EJ [1 ]
机构
[1] Tufts Univ, Lipid Metab Lab, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA
[2] Univ Penn, Dept Med, Philadelphia, PA 19004 USA
[3] Tufts Univ, Mass Spectrometry Lab, Jean Mayer USDA Hunam Nutr Res Ctr Aging, Boston, MA 02111 USA
[4] Univ Washington, NW Lipid Res Labs, Seattle, WA 98103 USA
[5] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6847, Australia
[6] Western Australia Inst Med Res, Perth, WA 6847, Australia
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2005年 / 54卷 / 03期
关键词
D O I
10.1016/j.metabol.2004.10.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The metabolism of apolipoproteins (apo) (a) and B-100 within plasma lipoprotein (a) [Lp(a)] was examined in the fed state in 23 subjects aged 41 to 79 years who received a primed-constant infusion of [5,5,5(-2) H(3)] leucine over 15 hours. Lipoprotein (a) was isolated from the whole plasma using a lectin affinity-based method. Apolipoprotein (a) and apoB-100 were separated by gel electrophoresis, and tracer enrichment of each apolipoprotein was measured using gas chromatography/mass spectrometry. Data were fit to a multicompartmental model to determine fractional catabolic rates (FCRs) and secretion rates (SRs). The FCRs of apo(a) and apoB-100 (mean SEM) within plasma Lp(a) were significantly different (0.220 +/- 0.030 pool/d and 0.416 +/- 0.040 pool/d, respectively; P < .001). Apolipoprotein (a) SR (0.50 +/- 0.08 mg/[kg per d]) was significantly lower than that of apoB-100 SR (1.53 +/- 0.22 mg/[kg per d]; P < .001) of Lp(a). Plasma concentrations of Lp(a) were correlated significantly with both apo(a) SR and apoB-100 SR (r = 0.837 and r = 0.789, respectively; P < .001) and negatively with apo(a) FCR and Lp(a) apoB-100 FCR (r = -0.547 and r = -0.717, respectively; P < .01). These data implicate different metabolic fates for apo(a) and apoB-100 within Lp(a) in the fed state. We therefore hypothesize that apo(a) does not remain covalently linked to a single apoB-100 lipoprotein but that it rather reassociates at least once with another apoB-100 particle, probably newly synthesized, during its plasma metabolism. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:361 / 369
页数:9
相关论文
共 49 条
  • [1] The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor
    Argraves, KM
    Kozarsky, KF
    Fallon, JT
    Harpel, PC
    Strickland, DK
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) : 2170 - 2181
  • [2] Lp(a) lipoprotein, vascular disease, and mortality in the elderly
    Ariyo, AA
    Thach, C
    Tracy, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (22) : 2108 - 2115
  • [3] Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger - A prospective study
    Bostom, AG
    Cupples, LA
    Jenner, JL
    Ordovas, JM
    Seman, LJ
    Wilson, PWF
    Schaefer, EJ
    Castelli, WP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (07): : 544 - 548
  • [4] A PROSPECTIVE INVESTIGATION OF ELEVATED LIPOPROTEIN(A) DETECTED BY ELECTROPHORESIS AND CARDIOVASCULAR-DISEASE IN WOMEN - THE FRAMINGHAM HEART-STUDY
    BOSTOM, AG
    GAGNON, DR
    CUPPLES, LA
    WILSON, PWF
    JENNER, JL
    ORDOVAS, JM
    SCHAEFER, EJ
    CASTELLI, WP
    [J]. CIRCULATION, 1994, 90 (04) : 1688 - 1695
  • [5] Brewer Jr HB, 1990, LIPOPROTEIN A, P211
  • [6] MODELS TO INTERPRET KINETIC DATA IN STABLE ISOTOPE TRACER STUDIES
    COBELLI, C
    TOFFOLO, G
    BIER, DM
    NOSADINI, R
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 253 (05): : E551 - E564
  • [7] MEASUREMENT OF VERY LOW-DENSITY AND LOW-DENSITY-LIPOPROTEIN APOLIPOPROTEIN (APO)-B-100 AND HIGH-DENSITY-LIPOPROTEIN APO-A-I PRODUCTION IN HUMAN-SUBJECTS USING DEUTERATED LEUCINE - EFFECT OF FASTING AND FEEDING
    COHN, JS
    WAGNER, DA
    COHN, SD
    MILLAR, JS
    SCHAEFER, EJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (03) : 804 - 811
  • [8] LIPOPROTEIN LP(A) LEVELS ARE REDUCED BY DANAZOL, AN ANABOLIC-STEROID
    CROOK, D
    SIDHU, M
    SEED, M
    ODONNELL, M
    STEVENSON, JC
    [J]. ATHEROSCLEROSIS, 1992, 92 (01) : 41 - 47
  • [9] Lipoprotein(a) and coronary heart disease - Meta-analysis of prospective studies
    Danesh, J
    Collins, R
    Peto, R
    [J]. CIRCULATION, 2000, 102 (10) : 1082 - 1085
  • [10] The metabolism of lipoprotein(a) and other apolipoprotein B-containing lipoproteins: a kinetic study in humans
    Demant, T
    Seeberg, K
    Bedynek, A
    Seidel, D
    [J]. ATHEROSCLEROSIS, 2001, 157 (02) : 325 - 339